|
|
| | Imatinib Impurity 72 Basic information |
| Product Name: | Imatinib Impurity 72 | | Synonyms: | Piperazinium, 1-methyl-1,4-bis[[4-[[[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]amino]carbonyl]phenyl]methyl]-;Imatinib Imp.R;Imatinib H;1-Methyl-1,4-bis[[4-[[[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]amino]carbonyl]phenyl]methyl]-piperazinium
DISCONTNUED;1-Methyl-1,4-bis(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazin-1-ium (Imatinib Impurity);Imatinib EP Impurity D (Imatinib Dimer);Imatinib Impurity 72 | | CAS: | 1821122-73-9 | | MF: | C53H51N12O2+ | | MW: | 888.07 | | EINECS: | | | Product Categories: | | | Mol File: | 1821122-73-9.mol |  |
| | Imatinib Impurity 72 Chemical Properties |
| solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | Pale Yellow to Light Yellow |
| | Imatinib Impurity 72 Usage And Synthesis |
| Uses | 1-Methyl-1,4-bis[[4-[[[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]amino]carbonyl]phenyl]methyl]-piperazinium is an impurity of Imatinib Mesylate (G407000), a tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). It is a COVID19-related research product. |
| | Imatinib Impurity 72 Preparation Products And Raw materials |
|